We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Both Parties' Motions Shot Down In Ethyol Patent Suit

Law360 (April 1, 2009, 12:00 AM EDT) -- In MedImmune Oncology Inc.'s protracted patent spat against Sun Pharmaceutical Industries Ltd. over the cancer therapy drug Ethyol, a federal judge has denied MedImmune's motion for partial summary judgment as to...
To view the full article, register now.